Weighted Average Number of Shares Outstanding, Basic of THC Therapeutics, Inc. from 31 Oct 2018 to 31 Jul 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
THC Therapeutics, Inc. annual and quarterly Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Oct 2018 to 31 Jul 2024.
  • THC Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Apr 2024 was 38,334,816, a 17% increase year-over-year.
  • THC Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 35,680,396, a 8.8% increase from 2023.
  • THC Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 32,806,009, a 1.3% decline from 2022.
  • THC Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 33,244,334, a 41% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

THC Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 35,680,396 +2,874,387 +8.8% 01 Aug 2023 31 Jul 2024 10-K 27 Feb 2026 2024 FY
2023 32,806,009 -438,325 -1.3% 01 Aug 2022 31 Jul 2023 10-K 27 Feb 2026 2024 FY
2022 33,244,334 +9,584,820 +41% 01 Aug 2021 31 Jul 2022 10-K 25 Nov 2022 2022 FY
2021 23,659,514 +7,108,180 +43% 01 Aug 2020 31 Jul 2021 10-K 25 Nov 2022 2022 FY
2020 16,551,334 +3,174,560 +24% 01 Aug 2019 31 Jul 2020 10-K 31 Mar 2022 2021 FY
2019 13,376,774 01 Aug 2018 31 Jul 2019 10-K 04 Nov 2020 2020 FY

THC Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 38,334,816 +5,588,667 +17% 01 Feb 2024 30 Apr 2024 10-Q 13 Nov 2024 2024 Q3
Q1 2023 32,746,149 +254,478 +0.78% 01 Feb 2023 30 Apr 2023 10-Q 13 Nov 2024 2024 Q3
Q3 2022 32,865,868 +582,354 +1.8% 01 Aug 2022 31 Oct 2022 10-Q 22 Dec 2022 2023 Q1
Q2 2022 33,244,334 +9,584,820 +41% 01 May 2022 31 Jul 2022 10-K 25 Nov 2022 2022 FY
Q1 2022 32,491,671 +8,313,811 +34% 01 Feb 2022 30 Apr 2022 10-Q 16 Jun 2022 2022 Q3
Q4 2021 35,685,938 +12,007,532 +51% 01 Nov 2021 31 Jan 2022 10-Q 16 May 2022 2022 Q2
Q3 2021 32,283,514 +10,505,619 +48% 01 Aug 2021 31 Oct 2021 10-Q 22 Dec 2022 2023 Q1
Q2 2021 23,659,514 +7,108,180 +43% 01 May 2021 31 Jul 2021 10-K 25 Nov 2022 2022 FY
Q1 2021 24,177,860 +9,487,696 +65% 01 Feb 2021 30 Apr 2021 10-Q 16 Jun 2022 2022 Q3
Q4 2020 23,678,406 +10,603,590 +81% 01 Nov 2020 31 Jan 2021 10-Q 16 May 2022 2022 Q2
Q3 2020 21,777,895 +7,029,841 +48% 01 Aug 2020 31 Oct 2020 10-Q 16 May 2022 2022 Q1
Q2 2020 16,551,334 +3,174,560 +24% 01 May 2020 31 Jul 2020 10-K 31 Mar 2022 2021 FY
Q1 2020 14,690,164 +1,615,348 +12% 01 Feb 2020 30 Apr 2020 10-Q 22 Jun 2021 2021 Q3
Q4 2019 13,074,816 0 0% 01 Nov 2019 31 Jan 2020 10-Q 29 Mar 2021 2021 Q2
Q3 2019 14,748,054 +1,744,465 +13% 01 Aug 2019 31 Oct 2019 10-Q 17 Dec 2020 2021 Q1
Q2 2019 13,376,774 01 May 2019 31 Jul 2019 10-K 04 Nov 2020 2020 FY
Q1 2019 13,074,816 01 Feb 2019 30 Apr 2019 10-Q 22 Jun 2020 2020 Q3
Q4 2018 13,074,816 01 Nov 2018 31 Jan 2019 10-Q 23 Mar 2020 2020 Q2
Q3 2018 13,003,589 01 Aug 2018 31 Oct 2018 10-Q 23 Dec 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.